Now Reading: India’s pharma exports up 6.8% to $8.1 billion in Q1
-
01
India’s pharma exports up 6.8% to $8.1 billion in Q1
India's pharmaceutical exports rose 6.8% to $8.1 billion in the first quarter of FY27, from $7.58 billion a year earlier, driven by demand for formulations, bulk drugs and vaccines, the Pharmaceuticals Export…
The Story in Brief
India's pharmaceutical exports rose 6.8% to $8.1 billion in the first quarter of FY27, from $7.58 billion a year earlier, driven by demand for formulations, bulk drugs and vaccines, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) said. June exports jumped 7.1% year-on-year to $2.8 billion. Vaccine exports were the fastest-growing segment, climbing 35.68% to $0.39 billion, while bulk drugs and intermediates grew 13.84% to $1.36 billion.
The United States remained India's top country-level market with $2.5 billion in shipments, followed by Brazil, Britain, the Netherlands and France. Pharmexcil chairman Namit Joshi cited growth across Europe, Africa, Latin America, ASEAN and South Asia despite geopolitical turbulence.
The Indian Opinion
The 35.68% surge in vaccine exports shows India's manufacturing has moved well beyond basic generics, yet the official narrative sidesteps how tariff threats and US drug pricing reforms could hit the $2.5 billion American market. The real test will be whether export volumes hold if Washington demands price cuts or imposes trade barriers.
Source: timesofindia.indiatimes.com
This story was synthesised by AI from the source linked above.
